226 related items for PubMed ID: 23345132
1. Androgen synthesis in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Kamrath C, Hartmann MF, Wudy SA.
Horm Metab Res; 2013 Feb; 45(2):86-91. PubMed ID: 23345132
[Abstract] [Full Text] [Related]
2. The activities of 5α-reductase and 17,20-lyase determine the direction through androgen synthesis pathways in patients with 21-hydroxylase deficiency.
Kamrath C, Hartmann MF, Remer T, Wudy SA.
Steroids; 2012 Nov; 77(13):1391-7. PubMed ID: 22951291
[Abstract] [Full Text] [Related]
3. Non-Classic Disorder of Adrenal Steroidogenesis and Clinical Dilemmas in 21-Hydroxylase Deficiency Combined with Backdoor Androgen Pathway. Mini-Review and Case Report.
Sumińska M, Bogusz-Górna K, Wegner D, Fichna M.
Int J Mol Sci; 2020 Jun 29; 21(13):. PubMed ID: 32610579
[Abstract] [Full Text] [Related]
4. Increased activation of the alternative "backdoor" pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis.
Kamrath C, Hochberg Z, Hartmann MF, Remer T, Wudy SA.
J Clin Endocrinol Metab; 2012 Mar 29; 97(3):E367-75. PubMed ID: 22170725
[Abstract] [Full Text] [Related]
5. [The alternative androgen synthesis pathway in humans].
Kamrath C, Hartmann MF, Wudy S.
Klin Padiatr; 2013 Jan 29; 225(1):3-7. PubMed ID: 23329621
[Abstract] [Full Text] [Related]
6. Alternative pathway androgen biosynthesis and human fetal female virilization.
Reisch N, Taylor AE, Nogueira EF, Asby DJ, Dhir V, Berry A, Krone N, Auchus RJ, Shackleton CHL, Hanley NA, Arlt W.
Proc Natl Acad Sci U S A; 2019 Oct 29; 116(44):22294-22299. PubMed ID: 31611378
[Abstract] [Full Text] [Related]
7. Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone.
Homma K, Hasegawa T, Nagai T, Adachi M, Horikawa R, Fujiwara I, Tajima T, Takeda R, Fukami M, Ogata T.
J Clin Endocrinol Metab; 2006 Jul 29; 91(7):2643-9. PubMed ID: 16608896
[Abstract] [Full Text] [Related]
8. Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia.
Jones CM, Mallappa A, Reisch N, Nikolaou N, Krone N, Hughes BA, O'Neil DM, Whitaker MJ, Tomlinson JW, Storbeck KH, Merke DP, Ross RJ, Arlt W.
J Clin Endocrinol Metab; 2017 Jun 01; 102(6):1797-1806. PubMed ID: 27845856
[Abstract] [Full Text] [Related]
9. The in vitro metabolism of 11β-hydroxyprogesterone and 11-ketoprogesterone to 11-ketodihydrotestosterone in the backdoor pathway.
van Rooyen D, Gent R, Barnard L, Swart AC.
J Steroid Biochem Mol Biol; 2018 Apr 01; 178():203-212. PubMed ID: 29277707
[Abstract] [Full Text] [Related]
10. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche.
Lucky AW, Rosenfield RL, McGuire J, Rudy S, Helke J.
J Clin Endocrinol Metab; 1986 May 01; 62(5):840-8. PubMed ID: 3007557
[Abstract] [Full Text] [Related]
11. Androgen biosynthesis during minipuberty favors the backdoor pathway over the classic pathway: Insights into enzyme activities and steroid fluxes in healthy infants during the first year of life from the urinary steroid metabolome.
Dhayat NA, Dick B, Frey BM, d'Uscio CH, Vogt B, Flück CE.
J Steroid Biochem Mol Biol; 2017 Jan 01; 165(Pt B):312-322. PubMed ID: 27471148
[Abstract] [Full Text] [Related]
12. Androgens in Congenital Adrenal Hyperplasia.
Pignatelli D, Pereira SS, Pasquali R.
Front Horm Res; 2019 Jan 01; 53():65-76. PubMed ID: 31499506
[Abstract] [Full Text] [Related]
13. New insights into steroidogenesis in normo- and hyperandrogenic polycystic ovary syndrome patients.
Medeiros SF, Gil-Junior AB, Barbosa JS, Isaías ED, Yamamoto MM.
Arq Bras Endocrinol Metabol; 2013 Aug 01; 57(6):437-44. PubMed ID: 24030183
[Abstract] [Full Text] [Related]
14. Assessment of the potential of polyphenols as a CYP17 inhibitor free of adverse corticosteroid elevation.
Lin CJ, Cheng LC, Lin TC, Wang CJ, Li LA.
Biochem Pharmacol; 2014 Aug 01; 90(3):288-96. PubMed ID: 24875446
[Abstract] [Full Text] [Related]
15. Androgen excess is due to elevated 11-oxygenated androgens in treated children with congenital adrenal hyperplasia.
Kamrath C, Wettstaedt L, Boettcher C, Hartmann MF, Wudy SA.
J Steroid Biochem Mol Biol; 2018 Apr 01; 178():221-228. PubMed ID: 29277706
[Abstract] [Full Text] [Related]
16. Late-onset congenital adrenal hyperplasia in women with hirsutism.
Arnaout MA.
Eur J Clin Invest; 1992 Oct 01; 22(10):651-8. PubMed ID: 1333959
[Abstract] [Full Text] [Related]
17. On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism.
Azziz R, Rafi A, Smith BR, Bradley EL, Zacur HA.
J Clin Endocrinol Metab; 1990 Feb 01; 70(2):431-6. PubMed ID: 2137133
[Abstract] [Full Text] [Related]
18. Steroid 17-Hydroxyprogesterone in Hair Is a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.
Auer MK, Krumbholz A, Bidlingmaier M, Thieme D, Reisch N.
Neuroendocrinology; 2020 Feb 01; 110(11-12):938-949. PubMed ID: 31711056
[Abstract] [Full Text] [Related]
19. Androglottia in a young female adolescent with congenital adrenal hyperplasia and 21-hydroxylase deficiency.
Fürst-Recktenwald S, Dörr HG, Rosanowski F.
J Pediatr Endocrinol Metab; 2000 Feb 01; 13(7):959-62. PubMed ID: 10968487
[Abstract] [Full Text] [Related]
20. [Comparative characteristics of steroidogenesis and its biorhythm in the hyperfunctioning adrenal cortex].
Kolesnikova GS, Goncharov NP, Vorontsov VI, Marova EI, Rozhinskaia LIa.
Vestn Ross Akad Med Nauk; 1994 Feb 01; (12):39-44. PubMed ID: 7742657
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
